Skip to content

Clinical trials

Epilepsy, Generalized trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy, Generalized Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20111
20181
20191
20201
20211
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lundbeck LLC2
Bio-Signal Group Corp.1
Biohaven Therapeutics Ltd.1
Mayo Clinic1
National Institute of Neurological Disorders and Stroke (NINDS)1
NeuroPro Therapeutics, Inc.1
Northwell Health1
Oregon Health and Science University1
Pfizer1
Rachel Kuperman1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy, Generalized14
Seizures8
Epilepsy7
Epilepsies, Partial4
Drug Resistant Epilepsy3
Epilepsy, Absence3
Lennox Gastaut Syndrome3
Autistic Disorder1
Depressive Disorder1
Epilepsy, Complex Partial1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.